|
Research Management and Support
|
RMS ES 2015
|
$348,215,937
|
$108,000
|
Unknown, Unknown
|
National Cancer Institute
|
|
INCREMENTAL SEVERABLE FUNDING FOR THE NCI AT FREDERICK
|
261200800001E
|
$205,925,847
|
$0
|
HEIMBROOK, DAVID
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-02
|
$24,080,302
|
$1,926,424
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-39
|
$7,704,373
|
$385,219
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$145,859
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Regional Oncology Research Center
|
5P30CA006973-52
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
$249,247
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Cancer Center Support Grant Year 35 (CCSG)
|
5P30CA021765-36
|
$6,012,603
|
$120,252
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-21
|
$4,271,782
|
$427,178
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
5P30CA013696-41
|
$3,792,720
|
$151,709
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Pediatric Oncology Branch Clinical Care and Education
|
ZIE BC 011516
|
$3,191,605
|
$159,580
|
Merchant, Melinda
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$189,310
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-33
|
$2,529,146
|
$202,332
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Georgetown University Lombardi Cancer Center Support Grant
|
5P30CA051008-22
|
$2,246,754
|
$67,403
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-13
|
$1,932,287
|
$483,072
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-07
|
$1,560,000
|
$15,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
5U01CA168426-04
|
$1,232,072
|
$1,232,072
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Immunobiology and Immunotherapy of Pediatric Cancer
|
ZIA BC 011073
|
$1,033,813
|
$103,381
|
Mackall, Crystal
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S5
|
$917,771
|
$73,422
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S7
|
$778,576
|
$62,286
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Development of antibody-based cancer therapies
|
ZIA BC 010891
|
$770,281
|
$770,281
|
Ho, Mitchell
|
CCR (NCI)
|
|
Targeting Neuroblastoma with armed T cells
|
5R01CA182526-02
|
$753,575
|
$753,575
|
LUM, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Molecular Diagnostics for Risk Stratification and Monitoring of Neuroblastoma
|
5R01CA182633-02
|
$671,686
|
$671,686
|
ASGHARZADEH, SHAHAB
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-05
|
$654,642
|
$477,889
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways
|
5R01CA057138-24
|
$636,692
|
$318,346
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
1R01CA180692-01A1
|
$623,838
|
$623,838
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-08
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
HiTIF Microscopy Core Facility
|
ZIC BC 011567
|
$611,751
|
$122,350
|
Pegoraro, Gianluca
|
CCR (NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIA BC 010788
|
$605,348
|
$363,209
|
Thiele, Carol
|
CCR (NCI)
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-02S4
|
$593,811
|
$47,505
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$539,792
|
$215,917
|
Khan, Javed
|
CCR (NCI)
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIA BC 010390
|
$501,603
|
$100,321
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$501,603
|
$50,160
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$481,042
|
$24,052
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Quantitative SPECT for Targeted Radionuclide Therapy
|
5R01CA109234-10
|
$420,010
|
$105,003
|
FREY, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-02
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
MYC--Transcription and Apoptosis
|
5R01CA051497-24
|
$394,000
|
$197,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-07
|
$378,479
|
$378,479
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$376,957
|
$33,926
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$376,957
|
$37,696
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
HAUSP inhibitors in p53-wild type and p53-mutant tumors
|
1R01CA193890-01
|
$366,000
|
$91,500
|
GU, WEI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
|
5R01CA148688-05
|
$363,125
|
$363,125
|
GEORGE, RANI
|
DANA-FARBER CANCER INST
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF PEDIATRIC CANCERS
|
ZIA BC 011002
|
$359,862
|
$359,862
|
Khan, Javed
|
CCR (NCI)
|
|
Pediatric Preclinical Testing Consortium
|
1U01CA199287-01
|
$357,000
|
$357,000
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
|
1R01CA197964-01
|
$350,628
|
$175,314
|
KITLINSKA, JOANNA
|
GEORGETOWN UNIVERSITY
|
|
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
|
5R01CA168903-04
|
$345,402
|
$345,402
|
FERRER, FERNANDO
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cells
|
5R01CA174808-02
|
$326,348
|
$326,348
|
SHOHET, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
|
ZIA BC 010789
|
$325,957
|
$293,361
|
Thiele, Carol
|
CCR (NCI)
|
|
Acidic Phospholipid-Selective Treatment for Neuroblastoma
|
5R01CA158372-05
|
$325,282
|
$325,282
|
QI, XIAOYANG
|
UNIVERSITY OF CINCINNATI
|
|
Optimizing 131I-mIBG Therapy for Children with Advanced Neuroblastoma
|
5R01CA172067-03
|
$324,006
|
$324,006
|
DUBOIS, STEVEN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Neuroblastoma for this search: $19,155,625
|